Drug Induced Vomiting
Drug Induced Vomiting
Drug Induced Vomiting
I. Introduction
Every drug can produce untoward consequences and side effects, even when used according to
standard or recommended methods for administration. Adverse drug reactions can involve every organ and
system of the body and are frequently mistaken for signs of underlying disease. Similarly, gastrointestinal tract
can be affected by many drugs or chemicals.
Among the drug-induced gastrointestinal adverse effects, nausea and vomiting are common side effects
of drugs; usually occur early in the course of pharmacologic therapy [1]. Often, the symptoms will disappear
with continued use. In some instances, concurrent administration of anti-emetics may be needed to prevent
dehydration and electrolyte imbalances [2,3]. Nausea and vomiting are not always simple adverse effects; in
some instances, the nausea and vomiting is a sign of a more serious situation. For example, nausea and vomiting
associated with digoxin or theophylline may be a sign of drug toxicity [3].
Vomiting is forceful oral expulsion of gastric contents associated with contraction of the abdominal and chest
wall musculature [4] Nausea is the unpleasant sensation of the imminent need to vomit, usually referred to the
throat or epigastrium; a sensation that may or may not ultimately lead to the act of vomiting [4].
The significant causes of nausea and vomiting include iatrogenic causes, toxicity, infectious causes,
gastrointestinal disorders, and central nervous system or psychiatric conditions.Among iatrogenic causes,
chemotherapeutic agents are the most well known. Infectious and toxic causes are usually self-limiting and
include viral gastroenteritis as well as bacteria and their toxins. Gastrointestinal disorders are often caused by an
inflammatory process, such as appendicitis, cholecystitis, or pancreatitis, or may be caused by obstruction or
motility problems. Central nervous system or psychiatric causes include increases in intracranial pressure,
migraine, and emotional or physical stressors.
In general, medications are associated with an increasing incidence of drug-induced (iatrogenic)
complications. According to one study, the gastrointestinal tract was associated with 20% to 40% of the drug-
induced adverse effects [5] Many gastrointestinal side effects, such as nausea, vomiting, dyspepsia, abdominal
cramps, diarrhea, or constipation, occur without any identifiable lesion or cause [6, 7]. Usually, these effects are
transient and resolve shortly after the drug is discontinued. However, there are some widely prescribed drugs
that cause serious and lasting adverse effects (mucosal ulceration, stricture, or increased susceptibility to
pseudomembranous colitis) [7]. In some situations, the adverse effects are worse than the illness for which the
drug was prescribed [7]. Over time, these adverse effects may impact a patient's nutritional status. The elderly
are most susceptible to these effects.
When a patient who is not receiving chemotherapy presents with nausea, it is often difficult to
determine the cause. In addition to medications, other causes (eg, migraine, emotional response, pregnancy, and
gastrointestinal disorders) must be considered. Nausea caused by medications is typically acute rather than
chronic and usually is seen shortly after starting a medication[9]. Medications can cause nausea via several
mechanisms. Dopaminergic agonists, nicotine, digoxin, and opiates have been shown to act on the area
postrema. Some agents (eg, nonsteroidal anti-inflammatory drugs [NSAIDs] and erythromycin) activate
peripheral afferent pathways, stimulating the brainstem nuclei [9]. Nausea also can be induced through
stimulation and activation of the chemoreceptor trigger zone (CTZ). Stimuli cause the CTZ to recognize a
substance as foreign and activate the vomiting center.
The most common substances to cause stimulation are chemotherapy drugs, opiates, and ipecac syrup.
Many other drugs (eg, antibiotics, NSAIDs, selective serotonin reuptake inhibitors [SSRIs], and digoxin) also
can cause the activation of the CTZ[9]. The mechanism associated with a number of medication classes known
to cause nausea remains unclear. Some of these include anti-arrhythmics, antihypertensives, diuretics, oral
hypoglycemics, and oral contraceptives [9]. See in table 1.
Many factors contribute to the severity of chemotherapy-induced vomiting [10]. Each drug has a
specific emetogenic potential (eg, minimal, moderate, high)[10]. For example, cisplatin has a high emetogenic
potential and vinblastine has minimal emetogenic potential. Depending on the chemotherapeutic drug, the
emetogenic potential can increase with escalating dose[11].The emetogenic potential of cyclophosphamide can
be moderate or high depending upon the dose. When chemotherapeutic drugs such as cyclophosphamide and
doxorubicin are co- administered, the emetogenic potential is greater than that of either drug
alone[11,12]. Chemotherapy-induced vomiting is more common in females and younger patients [12]. See in
table 2.
• Dexrazoxane
• Fludarabine
• Gemtuzumab
• Interferon alfa (low dose)
• Ipilimumab
• Methotrexate
• Nelarabine
• Ofatumumab
• Panitumumab
• Pegaspargase
• Peginterferon
• Pertuzumab
• Rituximab
• Temsirolimus
• Trastuzumab
• Valrubicin
• Vinblastine
• Vincristine
• Vincristine,
• Vinorelbine
Moderate risk (30% to 90%) of vomiting: • Aldesleukin (higher doses)
• Amifostine (higher doses)
• Arsenic trioxide
• Azacitidine
• Bendamustine
• Busulfan (high doses)
• Carboplatin
• Carmustine (lower doses)
• Clofarabine
• Cyclophosphamide (lower doses)
• Cytarabine (high doses)
• Dactinomycin
• Daunorubicin
• Doxorubicin
• Epirubicin
• Idarubicin
• Ifosfamide
• Interferon alfa (higher doses)
• Irinotecan
• Melphalan (higher doses)
• Methotrexate (high doses)
• Oxaliplatin
• Temozolomide
High risk (greater than 90%) of vomiting: AC combination which is doxorubicin given with
cyclophosphamide
• Carmustine (high-dose)
• Cisplatin (moderate to high doses)
• Cyclophosphamide (high-dose)
• Dacarbazine
• Doxorubicin (high doses)
• Epirubicin
• Ifosfamide (high doses)
• Streptozocin
Moderate to high risk of Altretamine
vomiting: • Busulfan (high doses)
• Crizotinib
• Cyclophosphamide (high doses)
• Estramustine
• Etoposide
• Lomustine (single day)
• Mitotane
• Procarbazine
• Temozolomide (high doses)
• Vismodegib
Pharmacologic Agents
When non- pharmacologic recommendations do not work, patients can turn to pharmacologic agents to
prevent and/or treat nausea caused by medication use. Dopamine antagonists, such as promethazine and
prochlorperazine, are especially effective for opioid-induced nausea, but can be beneficial for nausea caused by
other medications as well. They are a good choice for short-term offenders, such as antibiotics and NSAIDS.
Long-term use may be limited by extrapyrimidal side effects. The use of serotonin receptor antagonists (eg,
ondansetron and granisetron) may be beneficial for long-term prevention of nausea.
II. Prevention
Preventing nausea caused by medication often can be achieved with a few simple reminders. Unless an
agent is meant to be taken on an empty stomach, patients can be advised to take their medications with food.
This is an easy way to prevent nausea, especially with notorious offenders, such as antibiotics, NSAIDS, and
multivitamins. The time of day a medication is taken may be an important consideration when preventing
nausea caused by dizziness. Taking medications such as Selective serotonin re-uptake inhibitors (SSRIs) at
bedtime prevents the vomiting center from being activated by dizziness because the body is asleep [16]
.
III. Conclusion
Many drugs can affect gastrointestinal injury including nausea and vomiting and that effect
patient`s nutritional status. Elderly patients need extra attending because of their medical condition
and concomitant drug therapy. Generally, most of the drugs reactions occur within 1 to 2 weeks
following initiation of therapy, reaction seen after 2 weeks are less likely to be due to medication use.
The majority of drug-induced gastrointestinal reactions are moderate in severity. Healthcare
professionals can play an important role in reducing the incidence of drug-induced GI disorders by
alerting the patient to the early warning signs and providing education to help patients prevent these
effects.
References
[1] Yamada T, Alpers DH, Owyang C, et al. Handbook of Gastroenterology. Philadelphia, Pa: Lippincott-Raven Publishers; 3rd edition,
2013 Ghahremani GG. Gastrointestinal complications of drug therapy. Abdom Imaging. 1999; 24:1-2.
[2] Clark-Vetri RJ. Management of chemotherapy-induced emesis. Pharm Times. 1999; 65:78-85.
[3] American Cancer Society and National Comprehensive Cancer Network. Nausea and Vomiting: Treatment Guidelines for Patients
with Cancer (Version IV 2007). www.nccn.org/patients/patient_gls.asp.
[4] Garrett K, Tsuruta K, Walker S, Jackson S, Sweat M. Managing nausea and vomiting. Current strategies. Crit Care Nurse.
2003;23(1):31-50.
[5] Jordan K, Sippel C, Schmoll HJ. Guidelines for antiemetic treatment of chemotherapy-induced nausea and vomiting: past, present,
and future recommendations. Oncologist. 2007;12:1143-1150.
[6] Quigley EM, Hasler WL, Parkman HP. AGA technical review on nausea and vomiting. Gastroenterology. 2001;120:263-286.
[7] Guyton AC. Physiology of gastrointestinal disorders. In: Guyton AC, Hall JE. Textbook of Medical Physiology. Philadelphia, Pa:
Elsevier Saunders; 2006:823–824.
[8] Baker PD, Morzorati SL, Ellett ML. The pathophysiology of chemotherapy-induced nausea and vomiting. GastroenterolNurs
2005;28:469–480
[9] Gatenby RA. The radiology of drug-induced disorders in the gastrointestinal tract. SeminRoentgenol. 1995;30:62-76.
[10] Bramble MG, Record CO. Drug-induced gastrointestinal disease. Drugs. 1978;15:451-463
[11] Lee A, Morris J. Drug-induced gastrointestinal disorders. The Pharmaceutical Journal. 1997;258:742-747.
[12] Byrd DC. NSAID-induced gastropathy: prevention and treatment strategies. Pharm Times. 1999;65:44-50.
[13] Lewis JH. Gastrointestinal injury due to medicinal agents. Am J Gastroenterol. 1986;81:819-834.
[14] Ratnaike RN, Jones TE. Mechanisms of drug-induced diarrhoea in the elderly. Drugs & Aging. 1998;13:245-253.
[15] Graumlich JF. Preventing gastrointestinal complications of NSAIDs. Postgrad Med. 2001;109117-120,123-128.